| Literature DB >> 33526699 |
Shinichi Fukuda1,2,3, Akhil Varshney1,2, Benjamin J Fowler4, Shao-Bin Wang1,2, Siddharth Narendran1,2,5, Kameshwari Ambati1,2, Tetsuhiro Yasuma4,6, Joseph Magagnoli7,8, Hannah Leung1,2, Shuichiro Hirahara1,2,9, Yosuke Nagasaka1,2, Reo Yasuma1,2,6, Ivana Apicella1,2, Felipe Pereira1,2,10, Ryan D Makin1,2, Eamonn Magner11, Xinan Liu11, Jian Sun1,2, Mo Wang12, Kirstie Baker12, Kenneth M Marion12, Xiwen Huang11, Elmira Baghdasaryan12,13, Meenakshi Ambati1,2,14, Vidya L Ambati14, Akshat Pandey1,2, Lekha Pandya1,2, Tammy Cummings7,8, Daipayan Banerjee1,2, Peirong Huang1,2, Praveen Yerramothu1,2, Genrich V Tolstonog15, Ulrike Held16, Jennifer A Erwin17, Apua C M Paquola17, Joseph R Herdy18, Yuichiro Ogura9, Hiroko Terasaki6, Tetsuro Oshika3, Shaban Darwish19,20, Ramendra K Singh19, Saghar Mozaffari19, Deepak Bhattarai21, Kyung Bo Kim21, James W Hardin7,22, Charles L Bennett7,8,23, David R Hinton24,25, Timothy E Hanson26,27, Christian Röver28, Keykavous Parang19, Nagaraj Kerur1,2,29,30, Jinze Liu11, Brian C Werner31, S Scott Sutton7,8, Srinivas R Sadda12,13, Gerald G Schumann16, Bradley D Gelfand1,2,32, Fred H Gage33, Jayakrishna Ambati34,2,30,35.
Abstract
Alu retroelements propagate via retrotransposition by hijacking long interspersed nuclear element-1 (L1) reverse transcriptase (RT) and endonuclease activities. Reverse transcription of Alu RNA into complementary DNA (cDNA) is presumed to occur exclusively in the nucleus at the genomic integration site. Whether Alu cDNA is synthesized independently of genomic integration is unknown. Alu RNA promotes retinal pigmented epithelium (RPE) death in geographic atrophy, an untreatable type of age-related macular degeneration. We report that Alu RNA-induced RPE degeneration is mediated via cytoplasmic L1-reverse-transcribed Alu cDNA independently of retrotransposition. Alu RNA did not induce cDNA production or RPE degeneration in L1-inhibited animals or human cells. Alu reverse transcription can be initiated in the cytoplasm via self-priming of Alu RNA. In four health insurance databases, use of nucleoside RT inhibitors was associated with reduced risk of developing atrophic macular degeneration (pooled adjusted hazard ratio, 0.616; 95% confidence interval, 0.493-0.770), thus identifying inhibitors of this Alu replication cycle shunt as potential therapies for a major cause of blindness.Entities:
Keywords: Alu; health insurance databases; macular degeneration; retina; retrotransposon
Year: 2021 PMID: 33526699 PMCID: PMC8017980 DOI: 10.1073/pnas.2022751118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205